Loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel diseaseJ Schultheiss, Bas Oldenburg, Nofel Mahmmod et al.|Alimentary Pharmacology & Therapeutics|2021Cited by 49
Su458 LOSS-OF-RESPONSE TO ANTI-TNFα CRITICALLY DEPENDS ON TREATMENT DURATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASEJ Schultheiss, Bas Oldenburg, Herma H. Fidder et al.|Gastroenterology|2021Cited by 0
721: IMMUNOMODULATOR WITHDRAWAL FROM ANTI-TNF THERAPY IS NOT ASSOCIATED WITH LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASERemi Mahmoud, Bas Oldenburg, J Schultheiss et al.|Gastroenterology|2022Cited by 0